亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Procalcitonin as a precise biomarker of aging process

總結
This invention shows daily aging process of all people. This invention helps "Longevity" of all people, suffering from the aging at all around the world. Blood level of procalcitonin shows daily aging process in 24 hours period of a day
詳細技術說明
This invention uses rapid or automatic test device for Diagnosis of daily procalcitonin level
合作類型
License agreement
附加資料
Patent Number: US20130252254A1
Application Number: US13506278A
Inventor: Soylemez, Mehmet Ali
Priority Date: 21 Mar 2012
Priority Number: US20130252254A1
Application Date: 9 Apr 2012
Publication Date: 26 Sep 2013
IPC Current: G01N0033566 | C12M000134 | G01N002164 | G01N0033573
US Class: 4350074 | 422069 | 4352872 | 436501
Title: Procalcitonin gene expression as a precise biomarker of aging process
Usefulness: Procalcitonin gene expression as a precise biomarker of aging process
Summary: The method, kit and device are useful for in-vitro diagnosis and/or complications and/or risk stratification of aging process, and its sequelae and concomitant illnesses and cardiovascular complications, and for stratification of patients for clinical decisions related to treatment or therapy of aging and/or complications, prognosis and prophylaxis of the aging process, assessment of degree of severity, course of aging, preferably aging process and its concomitant illnesses and sequelae as an accompaniment to therapy (all claimed).
主要類別
生物醫學
細分類別
DNA /基因工程
申請號碼
US20130252254
覆蓋範圍
US
專利信息
Status: Patent Application
國家/地區
土耳其

欲了解更多信息,請點擊 這裡
移動設備